
### [NCIT:C45569](http://purl.obolibrary.org/obo/NCIT_C45569)
**Label:** High Grade Lung Neuroendocrine Neoplasm

**Subclasses:** [NCIT:C7591](http://purl.obolibrary.org/obo/NCIT_C7591) (Combined Lung Carcinoma), [NCIT:C7267](http://purl.obolibrary.org/obo/NCIT_C7267) (Combined Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C4917](http://purl.obolibrary.org/obo/NCIT_C4917) (Small Cell Lung Carcinoma), [NCIT:C5672](http://purl.obolibrary.org/obo/NCIT_C5672) (Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C136496](http://purl.obolibrary.org/obo/NCIT_C136496) (Small Cell Lung Carcinoma by AJCC v7 Stage), [NCIT:C118815](http://purl.obolibrary.org/obo/NCIT_C118815) (Childhood Small Cell Lung Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36129](http://purl.obolibrary.org/obo/NCIT_C36129) (High Grade Lesion) 75.00%
- Thing 50.92%
- [NCIT:C36825](http://purl.obolibrary.org/obo/NCIT_C36825) (Malignant Neuroendocrine Cell) 43.90%
- [NCIT:C36761](http://purl.obolibrary.org/obo/NCIT_C36761) (Neoplastic Neuroendocrine Cell) 40.08%
- [NCIT:C36929](http://purl.obolibrary.org/obo/NCIT_C36929) (Malignant Endocrine Cell) 36.47%
- [NCIT:C36925](http://purl.obolibrary.org/obo/NCIT_C36925) (Neoplastic Endocrine Cell) 33.22%
- [NCIT:C3824](http://purl.obolibrary.org/obo/NCIT_C3824) (Lesion) 31.25%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) 30.63%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) 30.46%
- [NCIT:C36753](http://purl.obolibrary.org/obo/NCIT_C36753) (Neoplastic Epithelial Cell) 29.45%
- [NCIT:C36745](http://purl.obolibrary.org/obo/NCIT_C36745) (Abnormal Epithelial Cell) 29.44%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 28.23%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 27.48%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 27.36%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 26.78%


